The polymorphism of protein tyrosine phosphatase 1B (PTP1B) is associated with a decreased risk of CAD in the Han Chinese population [45], and the phosphodiesterase-1 (PC-1) variant was reported to be associated with metabolic syndrome in patients with CAD [46]. This evidence concerns the gene PTPN1 and coronary artery disorder.